冠昊生物
(300238)
| 流通市值：43.75亿 | | | 总市值：43.75亿 |
| 流通股本：2.65亿 | | | 总股本：2.65亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 140,951,077.71 | 121,854,759.37 | 106,780,152.15 | 106,645,462.87 |
| 应收票据及应收账款 | 63,022,682.9 | 57,946,787.32 | 59,545,736.88 | 63,709,363.04 |
| 应收账款 | 63,022,682.9 | 57,946,787.32 | 59,545,736.88 | 63,709,363.04 |
| 预付款项 | 2,579,608.81 | 9,668,348.23 | 2,075,119.15 | 7,257,944.54 |
| 其他应收款合计 | 1,626,040.81 | 2,300,314.45 | 2,205,177.66 | 6,250,244.7 |
| 存货 | 76,133,035.57 | 73,838,054.27 | 78,459,032.6 | 75,276,629.78 |
| 其他流动资产 | 20,250,649 | 16,823,995.27 | 16,724,518.68 | 14,474,663.91 |
| 流动资产合计 | 304,563,094.8 | 282,432,258.91 | 265,789,737.12 | 273,614,308.84 |
| 非流动资产: | | | | |
| 长期股权投资 | 48,490.18 | 48,490.18 | 4,489,812.53 | 19,316,439.23 |
| 其他权益工具投资 | 18,000,000 | 18,000,000 | 18,000,000 | 15,154,545.45 |
| 投资性房地产 | 8,346,662.17 | 8,457,946.21 | 8,569,230.25 | 8,680,514.29 |
| 固定资产 | 313,650,627.59 | 316,579,858.34 | 319,541,816.39 | 154,925,372.7 |
| 在建工程 | 2,743,282.31 | 2,542,364.88 | 2,542,364.88 | 124,105,646.48 |
| 使用权资产 | 7,881,403.32 | 9,138,937.54 | 10,383,342.13 | 11,938,658.04 |
| 无形资产 | 75,786,505.15 | 77,827,893 | 72,701,685.89 | 76,257,925.21 |
| 开发支出 | 28,714,360.37 | 27,522,291.54 | 26,619,457.5 | 25,568,848.9 |
| 商誉 | - | - | - | 1,753,899.07 |
| 长期待摊费用 | 3,098,448.34 | 3,057,356.36 | 3,260,108.72 | 3,510,134.61 |
| 递延所得税资产 | 18,199,164.92 | 18,342,913.9 | 18,420,720.17 | 15,055,246.69 |
| 其他非流动资产 | 1,736,528.93 | 292,500 | 4,081,555.83 | 438,500.02 |
| 非流动资产合计 | 478,205,473.28 | 481,810,551.95 | 488,610,094.29 | 456,705,730.69 |
| 资产总计 | 782,768,568.08 | 764,242,810.86 | 754,399,831.41 | 730,320,039.53 |
| 流动负债: | | | | |
| 短期借款 | 19,013,199.88 | 20,013,819.32 | 20,014,583.21 | 21,014,583.21 |
| 应付票据及应付账款 | 12,401,243.31 | 13,265,856.82 | 35,649,866.21 | 8,554,075.76 |
| 应付账款 | 12,401,243.31 | 13,265,856.82 | 35,649,866.21 | 8,554,075.76 |
| 预收款项 | 908,738.12 | 978,836.12 | 720,874.08 | 978,836.12 |
| 合同负债 | 28,725,715.96 | 27,372,908.72 | 28,762,770.74 | 32,441,686.76 |
| 应付职工薪酬 | 16,190,351.28 | 9,454,046.06 | 18,356,099.97 | 15,763,873.9 |
| 应交税费 | 7,790,089.91 | 12,164,972.99 | 7,982,583.69 | 11,167,086.15 |
| 其他应付款合计 | 71,932,624.56 | 55,167,189.53 | 58,625,557.85 | 65,788,641.2 |
| 一年内到期的非流动负债 | 5,594,173.59 | 5,858,032.52 | 5,720,129.93 | 6,599,689.85 |
| 其他流动负债 | 2,258,627.52 | 1,679,719.48 | 2,158,496.09 | 1,979,279.4 |
| 流动负债合计 | 164,814,764.13 | 145,955,381.56 | 177,990,961.77 | 164,287,752.35 |
| 非流动负债: | | | | |
| 长期借款 | 99,000,000 | 99,000,000 | 76,000,000 | 63,070,097.23 |
| 租赁负债 | 4,015,804.21 | 5,169,909.38 | 6,615,111.89 | 7,288,832.27 |
| 递延收益 | 18,819,949.44 | 19,124,426.97 | 19,428,904.5 | 19,733,382.03 |
| 递延所得税负债 | 6,198,777.59 | 6,679,251.81 | 6,772,950.03 | 4,866,165.84 |
| 非流动负债合计 | 128,034,531.24 | 129,973,588.16 | 108,816,966.42 | 94,958,477.37 |
| 负债合计 | 292,849,295.37 | 275,928,969.72 | 286,807,928.19 | 259,246,229.72 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 265,155,701 | 265,155,701 | 265,155,701 | 265,155,701 |
| 资本公积 | 594,420,828.47 | 594,541,559.87 | 594,541,559.87 | 600,545,861.28 |
| 其他综合收益 | -46,464,437.81 | -46,405,497.26 | -46,388,548.35 | -46,575,005.98 |
| 盈余公积 | 50,643,420.67 | 50,643,420.67 | 50,643,420.67 | 47,110,231.52 |
| 未分配利润 | -297,954,685.58 | -306,727,931.28 | -321,594,027.95 | -319,827,806.21 |
| 归属于母公司股东权益合计 | 565,800,826.75 | 557,207,253 | 542,358,105.24 | 546,408,981.61 |
| 少数股东权益 | -75,881,554.04 | -68,893,411.86 | -74,766,202.02 | -75,335,171.8 |
| 股东权益合计 | 489,919,272.71 | 488,313,841.14 | 467,591,903.22 | 471,073,809.81 |
| 负债和股东权益合计 | 782,768,568.08 | 764,242,810.86 | 754,399,831.41 | 730,320,039.53 |
| 公告日期 | 2025-08-28 | 2025-04-23 | 2025-04-23 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |